FDA Inspection 1243027 — Martin Kankam
The FDA completed an inspection of Martin Kankam on Jun 13, 2024 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 13, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Overland Park, KS (United States)
Additional Details
Clinical BA/BE